Author
University of California, Los AngelesORCID 0000-0002-2488-8468Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Hua Jiang, Sam P. Limsuwannarot, Kayla R. Kulhanek…·Anusha K. Kalbasi
The paper shows that T cells engineered with IL-9R have better tissue infiltration, stemness, and anti-tumor activity compared to those with an orthogonal IL-9 receptor, due to stronger and more specific JAK/STAT signaling.
Sang Pil Yoo, Xuegang Yuan, Claire Engstrom…·Gay M. Crooks
This study generates TCR-null CAR T cells from iPSCs by controlling CAR signaling stages, resulting in naive-like cells with enhanced cytotoxicity.
Yang Pan, John W. Phillips, Beatrice D. Zhang…·Yi Xing
IRIS identifies cancer immunotherapy targets from alternative splicing using transcriptomics data and validates them with patient T cells.
Min Chai, Meisheng Jiang, Laurent Vergnes…·Jing Huang
The paper identifies small molecules that activate autophagy to stimulate hair regeneration in various conditions.